Image default
Water News

Dr Reddy’s Laboratories launches cancer treatment drug Capecitabine in US

New Delhi:DrugmajorDr Reddy’s Laboratorieson Wednesday said it has launchedcancer treatment drugCapecitabine tablets in the US market.

The product is a therapeutic equivalent generic version of Xeloda (capecitabine) tablets approved by the US Food and Drug Administration (USFDA).

In a regulatory filing, Dr Reddy’s laboratories announced launch of Capecitabine tablets in the US.

Quoting IQVIA Health data, Dr Reddy’s said the Xeloda brand and generic had US sales of approximately USD 90 million for the most recent 12 months ending in October 2020.

Dr Reddy’s Capecitabine Tablets, USP are available in 150 mg and 500 mg strengths in bottle count sizes of 60 and 120, respectively.

Shares of Dr Reddy’s Laboratories were trading 0.98 per cent lower at Rs 4,650 apiece on BSE.

(Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.


Related posts

New process could safeguard water quality, environment and health: Pioneering single process can remove pollutants from waste water


What side effects might I expect from the COVID-19 vaccines?


Orbital ordering triggers nucleation-growth behavior of electrons in an inorganic solid


Leave a Comment